Safety Study of a Drug Tukhm-e-Kharpaza (Cucumis Melo Linn.)

Authors

  • Mohd Waseem Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, 9897638269
  • A. Rauf Department of Ilmul Advia, A.K.T.C., A.M.U., Aligarh.
  • Sumbul Rehman Department of Ilmul Advia, A.K.T.C., A.M.U., Aligarh.
  • Reesha Ahmed Department of Ilmul Advia, A.K.T.C., A.M.U., Aligarh.

Keywords:

Tukhm-e-Kharpaza, Safety study, Heavy metal, Pesticide, Cucumis melo

Abstract

Drugs used in traditional medicines are liable to be contaminated with toxic substances. Plants are prone to
be contaminated with agricultural practices and lead to depression, Memory loss, Loss of sensation, chronic
renal failure etc. Safety study of herbal drugs and food items is now mandatory as per WHO guidelines. A
critical evaluation of their safety is therefore important. One particular safety issue relates to the possibility
of contamination of herbal medicinal products. Herbal medicinal products may be toxic due to adulterer
with synthetic drugs or contaminated with harmful ingredients ranging from pesticides to heavy metals.
Lead was the most commonly found metal, followed by mercury and arsenic.


All the safety parameters were found below the permissible limit as per WHO guidelines, its shows that
the drug Tukhm-e-Kharpaza (Linn.) is free from toxicity.

References

1. Dey C. A. (1980): “Indian Medicinal Plants use in
Ayurvedic Preparation” Bishen Singh Mahendra Pal
Singh, Dehradun, pp 52.
2. Dolidas and Agarwal V.S. (1991): “Fruit Drugs Plants of
India”,1st Edi. Kalyani Publishers, New Delhi-Ludhiana,
pp.72
3. Anonymous (2009): “Indian Medicinal Plants”, Indian
Council of Medical Research, New Delhi Vol. VIII, pp.
210-221.
4. Lubhaya H. R. (1977): “Goswami Bayanul Advia”
Goswami pharmacy, Delhi,Vol.I, pp. 224-226.
5. Ibn Baitar (1985): “Al-Jameul Mufridat al Adviawa Al-
Aghzia” (Urdu Translation), CCRUM, New Delhi, Vol.I,
pp. 248-252.
6. Chopra R.N., Chopra I.C., Handa K.L. and Kapur L.D.
(2006): Indigenous Drugs of India, 3rd Edi. Academic
Publishers, Kolkata, pp.502.
7. Usmani M. I. (2008): “Tanqeehul Mufridat”, Ibn Sina
Tibbiya College, Azamgarh. p. 120.
8. Khory H. K. and Katrak N.N. (1985):“Materia Medica
of India and Therapeutics”, 3rd Edi, Neeraj PublishingKirtikar K.R. and Basu B.D. (1987): “Indian Medicinal
Plants”,2nd Edi. International Book Distributors,
Dehradun. Vol. II, pp.1140-1142.
10. Bhattacharjee S.K. (2004): “Handbook of Aromatic
Plants”, Pointer publishers, Jaipur, India. pp. 150.
11. Nabi M. G. (2007): “Makhzanul Mufridat wa Murakkabat
Maroof ba Khawasul Advia”, Part-3, CCRUM, New Delhi,
pp. 122.
12. Bhattacharjee S.K. and De L.C. (2005): “Medicinal Herbs
and Flowers” Aavishkar Publishers, Distributors Jaipur,
India,pp.114
13. Ghani N. (2010): “Khazainul Advia”, CCRUM, New Delhi,
Vol. IV, pp. 59-60.
14. Azam Khan (2013): “Muheet-e-Azam” (Urdu translation)
CCRUM, New Delhi. Vol. II, pp.430-435.
15. Anonymous, 2007: WHO guidelines for assessing quality
of herbal medicine with reference to contaminants and
residues, World Health Organization Geneva, pp.14-15.
16. Meritxell Ventura, Antonio, G. Anaya, I., Diaz, J.,
Broto, F., Agut, M., Comellas L. 2004: Determination
of Aflatoxin B1, G1, B2, G2, in medicinal herbs by liquid
chromatography- tandem mass spectrometry, Journal
chromatography A, 1048(2): 25-29.
17. Lohar, D.R., 2007: Protocol for testing of Ayurvedic,
Siddha & Unani Medicine pharmacopoeial Laboratory
for Indian Medicines, Ghaziabad, pp. 77-89.
18. Ramkrishanan, G. Gayathri V. Sathia, S. Parameswari,
R.P. Saravana, C B. 2015: Physicochemical and
phytochemical standardization of Thraatchathi
chooranam- A polyherbal formulation. Journal of
pharmaceutical Science & Research 7(6):305-313.
19. Anonymous 2004: WHO guidelines on safety monitoring
of herbal medicine in pharmacovigilance system WHO
Geneva.

Downloads

Published

2018-09-07

Issue

Vol. 1 No. 1&2 (2018): Journal of Advanced Research in BioChemistry and Pharmacology

Section

Research Article

License

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.